Law firm or agent

BIOHAVEN PHARMACEUTICALS, INC.

Save Like

76 applicationsfiled 2016 to 2026

Allowance rate

82%

+6 pts vs the USPTO range 67% to 91%

Rejections before allowance

1.7

+0.2 vs the USPTO

Months to first action

25.4 mo

+6.8 vs the USPTO

Needed an RCE

35%

+8 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations45 apps

C07D Heterocyclic compounds19 apps

A61P Therapeutic activity of compounds10 apps

F04D 1 apps

C07K Peptides1 apps

Art units

OPAP16 apps

16296 apps

16266 apps

16996 apps

16245 apps

16754 apps

Examiners met

The examiners seen most, and how it went with each

Docket Central15 apps

Noble E Jarrell5 apps

100%

Laura Lynne Stockton4 apps

100%

Laura Ann Essex3 apps

100%

Craig D Ricci3 apps

33%

Nizal S Chandrakumar3 apps

100%

Janet L Coppins3 apps

100%

Kahsay Habte2 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the examiners this firm meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who they file for

Clients with the most applications

Biohaven Therapeutics Ltd.54 apps

76%

KLEO PHARMACEUTICALS, INC.7 apps

75%

HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO., LTD3 apps

100%

Katholieke Universiteit Leuven3 apps

100%

ASTRAZENECA AB2 apps

100%

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.2 apps

100%

AMDA Biologics, Inc.1 apps

n/a

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LIMITED (B1 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the clients they file forIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19627969	BIFUNCTIONAL DEGRADERS	2026-09-25	Pending	0	0	n/a
19616482	BIFUNCTIONAL DEGRADERS OF ANTI-PLA2R ANTIBODY	2026-08-19	Pending	0	0	n/a
19607511	BIFUNCTIONAL DEGRADERS OF IgG4 IMMUNOGLOBULINS	2026-07-19	Pending	0	0	n/a
15462095	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15891578	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15844128	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15121740	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15365310	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15423193	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15857679	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 76 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in